BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35730647)

  • 1. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
    Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
    Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Coppedè F; Lopomo A; Spisni R; Migliore L
    World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of methylation markers in colorectal cancer (Review).
    Kong C; Fu T
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
    Raut JR; Guan Z; Schrotz-King P; Brenner H
    Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
    Postwala H; Shah Y; Parekh PS; Chorawala MR
    Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
    Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
    Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance.
    Zhao N; Lai C; Wang Y; Dai S; Gu H
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189096. PubMed ID: 38499079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.
    Zhang X; Hou H; Jiang M; Zhang X
    Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
    Gyparaki MT; Basdra EK; Papavassiliou AG
    J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
    Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
    Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review.
    Ghadiri Moghaddam F; Farajnia S; Karbalaei-Mahdi M; Monir L
    Mol Biol Rep; 2022 Oct; 49(10):10013-10022. PubMed ID: 35727475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
    Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
    Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.